AzTrials
AzTrials

Tracheal IntubationNCT02384564

King Vision Video Laryngoscope aBlade vs. Direct Laryngoscopy in Children

A study testing Ambu King Vision Video Laryngoscope aBlade and Direct Laryngoscopy via Miller Straight Blade in people with Tracheal Intubation, run by Ann & Robert H Lurie Children's Hospital of Chicago.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether there is a clinically relevant difference in first attempt success rates between the Ambu King Vision Video Laryngoscope and Direct Laryngoscopy in Children. Read more about this study

Who is it for?
Ages 1 day to 11 years
Conditions the study is for
Tracheal Intubation
What is being tested?
Ambu King Vision Video Laryngoscope aBlade and Direct Laryngoscopy via Miller Straight Blade
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
No sites listed yet
Study dates
Aug 2015to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • ASA (American Society of Anesthesiologists) I-III classified patients
  • Patients undergoing procedure where an endotracheal tube would be normally utilized

Who cannot join

  • Children with expected difficult airways
  • Coagulopathy

Trial locations and contacts

No sites are listed yet.

Narasimhan Jagannathan, MD contact

312275170

njagannathan@luriechildrens.org

About this study

Official title: A Randomized Comparison of the King Vision Video Laryngoscope aBlade vs. Direct Laryngoscopy in Children

The purpose of this study is to determine whether there is a clinically relevant difference in first attempt success rates between the Ambu King Vision Video Laryngoscope and Direct Laryngoscopy in Children.

Read the detailed description

The goal of this prospective randomized study is to compare whether there is a clinically relevant difference in the rate of first attempt successful intubation between the Ambu King Vision Video Laryngoscope and direct laryngoscopy using the Miller Blade Laryngoscope. Other parameters of clinical relevance such as grade of laryngeal view, percentage of glottic opening, number of insertion attempts, time for successful tracheal intubation, and complications will also be assessed.

Being tested
Ambu King Vision Video Laryngoscope aBlade, Direct Laryngoscopy via Miller Straight Blade
Keywords
Laryngoscopy, Video Laryngoscopy, Tracheal intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ambu King Vision Video Laryngoscope aBladeDevice

    Also called King Vision Video Laryngoscope

    At time of tracheal intubation, the subject will be intubated using the Ambu King Vision Video Laryngoscope with the appropriately sized Ambu aBlade System based on manufacturer guidelines and clinical judgement. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded via direct vision. Information on subsequent attempts, time to successful intubation, and ease of tracheal tube insertion will be assessed.

  • Direct Laryngoscopy via Miller Straight BladeDevice

    Also called Miller Blade, Wisconsin blade, Straight blade

    At time of tracheal intubation, the subject will be intubated via direct laryngoscopy using a straight laryngoscope blade, based on manufacturer guidelines and clinical judgement. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded via direct vision. Information on subsequent attempts, time to successful intubation, and ease of tracheal tube insertion will be assessed.

Study groups in NCT02384564
Study groupRoleWhat they receive
Ambu King Vision Video Laryngoscope aBlade SystemExperimentalThe trachea will be intubated using the Ambu King Vision Video Laryngoscope with the appropriate sized blade (size 1 or 2) based on manufacturer guidelines and clinical judgement.
Receives: Device: Ambu King Vision Video Laryngoscope aBlade
Direct LaryngoscopeActive comparatorThe trachea will be intubated via direct laryngoscopy using a traditional straight blade laryngoscope, with appropriately sized blade based on manufacturer guidelines and clinical judgement.
Receives: Device: Direct Laryngoscopy via Miller Straight Blade

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First Attempt Success Rate of Tracheal Intubation

    An attempt at tracheal intubation will be defined as entry of the device into the patient's mouth without the need to remove the device once entered and securing the airway.

    Measured: Assessed intraoperatively at time of intubation

Secondary outcomes (5)
  1. Grades of Laryngeal View

    Cormack Lehane (1-4) and percentage of glottic opening (POGO) (%) will be recorded after insertion of the laryngoscope.

    Measured: Assessed intraoperatively at time of intubation

  2. Time to Successful Intubation

    The time to intubation will be measured (seconds) to measure the time to intubation of the successful attempt.

    Measured: Assessed intraoperatively at time of intubation

  3. Intraoperative Complications

    Airway/device related complications including, laryngospasm, bronchospasm, regurgitation/aspiration, oxygen desaturation, will be measured.

    Measured: Assessed intraoperatively for the duration of the surgery

  4. Postoperative Complications

    Airway/device related complications including sore throat, hoarseness, persistent coughing, stridor, and others will be measured during the post-operative period.

    Measured: Outcome measure will be assessed postoperatively in the immediate phase 1 recovery unit for an average of 1 hour.

  5. Ease of Endotracheal Tube Passage

    The ease of tracheal tube passage will be measured following tracheal intubation.

    Measured: Assessed intraoperatively at time of intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2015 (estimated)
  2. Study startAug 2015
  3. Primary completionOct 2015 (estimated)
  4. Study completionOct 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02384564
Sponsor's protocol ID
IRB 2015-304
Status last verified
Jul 2015
First submitted
26 Feb 2015
Last updated
29 Jul 2015
Results posted
No
Data monitoring committee
No

Publications

  • Levitan RM, Heitz JW, Sweeney M, Cooper RM. The complexities of tracheal intubation with direct laryngoscopy and alternative intubation devices. Ann Emerg Med. 2011 Mar;57(3):240-7. doi: 10.1016/j.annemergmed.2010.05.035. Epub 2010 Jul 31.

    PubMed 20674088
  • Theiler L, Hermann K, Schoettker P, Savoldelli G, Urwyler N, Kleine-Brueggeney M, Arheart KL, Greif R. SWIVIT--Swiss video-intubation trial evaluating video-laryngoscopes in a simulated difficult airway scenario: study protocol for a multicenter prospective randomized controlled trial in Switzerland. Trials. 2013 Apr 4;14:94. doi: 10.1186/1745-6215-14-94.

    PubMed 23556410
  • Murphy LD, Kovacs GJ, Reardon PM, Law JA. Comparison of the king vision video laryngoscope with the macintosh laryngoscope. J Emerg Med. 2014 Aug;47(2):239-46. doi: 10.1016/j.jemermed.2014.02.008. Epub 2014 Apr 16.

    PubMed 24742495
  • Akihisa Y, Maruyama K, Koyama Y, Yamada R, Ogura A, Andoh T. Comparison of intubation performance between the King Vision and Macintosh laryngoscopes in novice personnel: a randomized, crossover manikin study. J Anesth. 2014 Feb;28(1):51-7. doi: 10.1007/s00540-013-1666-9. Epub 2013 Jun 30.

    PubMed 23812581

Questions about this trial

What is this clinical trial studying?

A study testing Ambu King Vision Video Laryngoscope aBlade and Direct Laryngoscopy via Miller Straight Blade in people with Tracheal Intubation, run by Ann & Robert H Lurie Children's Hospital of Chicago.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Narasimhan Jagannathan, MD (312275170, njagannathan@luriechildrens.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First Attempt Success Rate of Tracheal Intubation (time frame: Assessed intraoperatively at time of intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02384564, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in